Corrigendum to “Adjuvant and first line chemotherapy use for endometrial cancer” [Gynecol. Oncol. Rep. 41 (2022) 101002]
Main Authors: | Anne Knisely, Yongmei Huang, Yeran Li, Vimalanand S. Prabhu, Jason D. Wright |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578922001928 |
Similar Items
-
Corrigendum to “Pediatric ano-rectal necrosis” [J Pediatr Surg Case Rep 41 (February 2019) 12–14]
by: Keren Kremer, et al.
Published: (2023-10-01) -
Corrigendum to “Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome” [Taiwan J Obstet Gynecol 58 (2019) 183–187]
by: Shinji Katsuragi, et al.
Published: (2020-01-01) -
Corrigendum to “Efficacy and safety of intravenous dexmedetomidine as an adjuvant to general anesthesia in gynecological surgeries: A systematic review and meta-analysis of randomized controlled trials” [Taiwan J Obstet Gynecol 62 (2023) 239–251]
by: Tsung-Yu Hung, et al.
Published: (2024-01-01) -
Emergências em pneumologia oncológica
by: Fernando Nogueira
Published: (2007-11-01) -
Prognostic model for the exemption of adjuvant chemotherapy in stage IIIC endometrial cancer patients
by: Xi-Lin Yang, et al.
Published: (2022-10-01)